Pharm manuf/distr DIV - FSA

Active Indefinite Delivery Contract Awarded Last action

Contract number
SPE2D224D0008
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 42% complete
IDV ceiling
$5,892,883.55
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

Specgx LLC, operating as Mallinckrodt Pharmaceuticals, was awarded a single-award Indefinite Delivery Contract by the Defense Logistics Agency on September 27, 2024, with a ceiling value of $5.89 million and ultimate completion date of September 26, 2029. This contract establishes a national requirements supply source for Methylphenidate HCL immediate-release tablets in 5-milligram, 10-milligram, and 20-milligram strengths in 100-count bottle quantities. The contract is unrestricted and fully competitive, with no set-aside designation applied. The pharmaceutical products procured under this indefinite delivery vehicle are intended to support the Defense Logistics Agency, Bureau of Prisons, Indian Health Service, Department of Veterans Affairs, and their associated prime vendor programs, ensuring consistent national supply availability of this controlled substance medication.

The contract was issued on a firm-fixed-price basis with a one-year base period and four one-year option periods, enabling the federal government to issue delivery orders as required to meet ongoing operational and clinical needs across multiple federal healthcare and corrections systems. Specgx LLC's award reflects its established capability as a critical supplier of specialized pharmaceutical products to federal agencies, with particular expertise in controlled substance manufacturing and distribution. The indefinite delivery structure allows the government to manage demand across multiple agencies efficiently while maintaining a secure, dedicated supply source for Methylphenidate HCL, a Schedule II controlled substance commonly used in attention deficit hyperactivity disorder treatment and other medical applications requiring federal oversight.

Transactions

Action Obligated Date
Exercise an Option P00002 · 4610114675! $0
Change Order P00001 $0
Original award 4610114675 ! Pharm manuf/distr DIV - FSA $0

Quick answers

Who was awarded contract SPE2D224D0008?

SPE2D224D0008 was awarded to Specgx LLC by Medical Supply Chain (Troop Support) on September 27, 2024.

How much is contract SPE2D224D0008 worth?

SPE2D224D0008's own ceiling is $5,892,884.

Who can order from contract SPE2D224D0008?

SPE2D224D0008 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract SPE2D224D0008 competed?

The extent of competition for SPE2D224D0008 was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV